Literature DB >> 9623735

Natural history of thyroid eye disease.

P Perros1, P Kendall-Taylor.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9623735     DOI： 10.1089/thy.1998.8.423

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  15 in total

1.  Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study.

Authors:  Annamaria De Bellis; Giovanni Conzo; Gilda Cennamo; Elena Pane; Giuseppe Bellastella; Caterina Colella; Assunta Dello Iacovo; Vanda Amoresano Paglionico; Antonio Agostino Sinisi; Jack R Wall; Antonio Bizzarro; Antonio Bellastella
Journal:  Endocrine       Date:  2011-11-16       Impact factor: 3.633

2.  Histopathologic analysis of palpebral conjunctiva in thyroid-related orbitopathy (an american ophthalmological society thesis).

Authors:  Don O Kikkawa
Journal:  Trans Am Ophthalmol Soc       Date:  2010-12

3.  Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisited.

Authors:  Francesca Menconi; Maria Antonietta Profilo; Marenza Leo; Eleonora Sisti; Maria Antonietta Altea; Roberto Rocchi; Francesco Latrofa; Marco Nardi; Paolo Vitti; Claudio Marcocci; Michele Marinò
Journal:  Thyroid       Date:  2013-12-09       Impact factor: 6.568

4.  Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy.

Authors:  E Sisti; F Menconi; M Leo; M A Profilo; T Mautone; B Mazzi; R Rocchi; F Latrofa; M Nardi; P Vitti; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2015-01-18       Impact factor: 4.256

Review 5.  Graves' orbitopathy: imperfect treatments for a rare disease.

Authors:  Luigi Bartalena
Journal:  Eur Thyroid J       Date:  2013-11-20

Review 6.  [Graves' ophthalmopathy].

Authors:  A Eckstein; D Dekowski; D Führer-Sakel; U Berchner-Pfannschmidt; J Esser
Journal:  Ophthalmologe       Date:  2016-04       Impact factor: 1.059

7.  Locally produced insulin-like growth factor-1 by orbital fibroblasts as implicative pathogenic factor rather than systemically circulated IGF-1 for patients with thyroid-associated ophthalmopathy.

Authors:  Delu Song; Renyan Wang; Yong Zhong; Weiye Li; Hui Li; Fangtian Dong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-09       Impact factor: 3.117

8.  Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous?

Authors:  L Bartalena; C Marcocci; C A Gorman; W M Wiersinga; A Pinchera
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

Review 9.  [Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology].

Authors:  Anja Eckstein; Klaus Mann; George J Kahaly; Martin Grussendorf; Christoph Reiners; Joachim Feldkamp; Beate Quadbeck; Andreas Bockisch; Matthias Schott
Journal:  Med Klin (Munich)       Date:  2009-05-16

10.  [Update on endocrine orbitopathy].

Authors:  A Eckstein; U Berchner-Pfannschmidt; D Führer; J Esser
Journal:  Ophthalmologe       Date:  2013-11       Impact factor: 1.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.